This study chanlcterizes the HLA class I and class II antigens in a group of patients with vitiligo and a control group, both of Dutch descent. Earlier reports had shown a significant positive association with DR4 and a significant negative association with DR3. We found that, after correction for the broad antigens studied, only Cw7 and DR6 were significantly associated with vitiligo. The significant positive association of DR6 with vitiligo is interesting since vitiligo has an autoimmune component in its pathogenesis and DR6 may be a marker for high immune responsiveness.
INTRODUCTION
Vitiligo is a patchy disease with depigmentation of the skin which has a variable age of onset, equal sex distribution and is occasionally familial with an autosomal dominant mode of inheritance with variable penetrance and expression (Finco et ai, 1991) . This disease entity is commonly associated with several autoimmune diseases (McGregor et a!., 1972; Cunliffe et a!., 1969; Bor et al., 1969; Lerner, 1959) . The incidence of vitiligo in patients with autoimmune disease is 8% to 15 % compared to 1 % in the general population (Koransky, 1980) . There are autoantibodies directed against melanocytes (Bystryn and Pfeffer, 1988; Norris et ai, 1988) . Recent immunophenotyping studies suggest that cellular immunity against melanocytes may also be involved in vitiligo (Abdel-Nasser et a!., 1991). These observations suggest that there may be an autoimmune component in its etiology and pathogenesis. There is no consensus in previous reports of HLA-A and HLA-B associations with vitiligo in different caucasoid populations (Metzkeret al., 1980; Retornaz eta!., 1976; Gunther and Richter, 1976) . For that reason, we decided to carry out a search for HLA associations in patients with vitiligo in the Dutch caucasoid population. We attempted to confirm the earlier reports of a significant positive association with HLA-DR4 (Foley et aI., 1983) and of a sig- HLA-A, B, C typings were performed with the standard NIH Iympho-cytotoxity method (van Rood, 1979 ) and the HLA-DR, DQ typings with the two-colour fluorescence test (van Rood et aI., 1976) . All typings were performed in the HLA typing laboratory of the Central Laboratory of the Blood Transfusion Service, Amsterdam, The Netherlands.
Haldane's modification of Woolf's method was used to calculate the Relative Risk (RR) and its significance in this study (Woolf, 1955; Haldane, 1955) . When indicated, P values were corrected for multiple comparisons using the formula suggested by J.
Edwards: Pc= I -(I -pu)n, where Pu is the uncorrected and Pc the corrected p value and n is the number of comparisons (Edwards, 1974) . Antigenic splits were not included in the analyses because the validity of their estimated frequencies would be poor in the modest number of patients studied.
RESULTS
An overview of the borderline of clearly significantly different frequencies of the HLA-A, B, C, DR and DQ broad antigens in vitiligo patients and controls are set out in Table I . HLA-DR3 and DR4 are included in the table because other inve~gators have reported significant associations for those antigens (Finco et aI., 1991; Foley et al. , 1983) . In the set of 48 patients HLA-A2, B 14, DR4 and DR6 were increased and HLA-B7, Cw7 and DR3 were decreased. Among these 7 antigens, only Cw7 and DR6 were still significant after correction for the 45 broad HLA antigens (8+ 16+ 7 + I 0+4) which were examined (p values of 0.04 and 0.02 respectively). No additional significant differences were found in the remaining 38 (45-7) broad HLA antigens.
DISCUSSION
Foley et al. reported a significant positive association between HLA-DR4 and vitiligo (RR=2.367, Puncorr=0.0049) and Finco et at. , reported a negati ve association between HLA-DR3 and vitiligo (RR=0.4216). However, the p values in both studies were not corrected for the number of antigens examined.
In our results, HLA-Cw7 and DR6 are the only antigens which retain their significance after correction for the 45 antigens which were compared. That fact is interesting since vitiligo is commonly associated with several autoimmune diseases (McGregor et al., 1972; Cunliffe et ai., 1969; Bor et aI., 1969; Lerner, 1959) , where its incidence in patients with autoimmune disease is 8% to 15% compared to only I % in the general population (Koransky, 1980) , and there is evidence that DR6 may be a marker for high im'mune responsiveness Hendriks et ai., 1986; Hendriks et ai., 1983) . Table I because other investigators have reported significant associations for those antigens (Finco et al.. 1991; Foley et aI. , 1983 
